Answers are grounded in this paper and cite their sources.
Carbapenem-resistant Klebsiella pneumoniae is a prevalent, priority global pathogen, posing a grave infection risk and necessitating development of novel therapeutics. Wholegenome sequencing has been used to characterise carbapenemase-encoding genes, plasmids and other resistance determinants, with reports of high-risk Carbapenem-resistant Klebsiella pneumoniae clones globally. However, whole genome sequence detection does not directly measure protein expression or functional integration among resistance-associated proteins. In contrast, LC-MS/MS-based comparative proteomics of resistant and susceptible strains can reveal variations in protein abundance and stress-response pathways associated with resistance. Time-resolved proteomics can characterise dynamic protein responses under antibiotic stress and help investigate these responses in Carbapenem-resistant Klebsiella pneumoniae- beyond static endpoints. A critical next step is mapping the resistance interactome. Conventional approaches such as affinity purification and co-immunoprecipitation may not adequately capture some weak or transient interactions. Proximity labelling approaches such as mini-Turbo and APEX2 could help identify proteins in the vicinity of the selected bait protein in living cells. Furthermore, comparative proteomic analyses of isogenic strains before and after conjugation-mediated acquisition of resistance genes could help elucidate the proteomic consequences of horizontal gene transfer. Finally, integrating proteomic data with network analysis could help identify candidate resistance-associated hubs that warrant functional validation, complementing genomic analyses. Therefore, this review proposes a framework to move from characterising the resistome and resistance proteome to experimentally investigating the resistance interactome. Key points WGS identifies resistance-associated genes and genomic context but does not directly measure protein abundance, localisation or interactions.Proximity labelling has the potential to map the CRKP resistance interactome.Bridging resistome and interactome data may reveal new antibacterial drug targets.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: